Skip to main content
. 2022 Jul 21;12:12491. doi: 10.1038/s41598-022-16776-1

Figure 5.

Figure 5

The 29F.1A12 and RMP1-30 anti-PD-1 antibody clones recognize overlapping B16-F10 melanoma subpopulations. (a,b) Representative FACS plots of 29F.1A12 and RMP1-30 co-staining (left) and % dual positivity (mean ± s.e,m., calculated as a fraction of RMP1-30-reactive cells) of PD-1 surface protein expression (right) by live (FVD) (a) B16-F10 wild-type (WT) versus PD-1-overexpressing (OE) melanoma cells or (b) unactivated versus activated WT T-cells (C57BL/6) reveals co-localization of PD-1 antibody binding. (c,d) Representative histograms (left) and % positivity (mean ± s.e.m.) of PD-1 surface protein expression (right) by live (FVD) B16-F10 WT cells grown in standard (2D, black line) versus tumor spheroid (3D, red line) culture conditions, as determined by the (c) 29F.1A12 or (d) RMP1-30 anti-mouse PD-1 antibody clones. Results are representative of at least n = 3 independent experiments. *p < 0.01; ***p < 0.001.